Rwwine, I am never surprised at shortsightedness and fear driving a stock down, or for that matter the stock market. Most Biotech stocks took a beating today. Did they all have bad news? Obviously not.
I have a lot of confidence in ENTA given how impressive the EDP-235 phase 2 trial data was.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.